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Summary 
The chemokine ~ family is comprised of at least six distinct cytokines that regulate trafficking 
of phagocytes and  lymphocytes in  mammalian species; at  least  one  of these,  macrophage 
inflammatory protein lcr (MIP-loL), also regulates  the growth of hematopoietic stem cells. We 
now show that MIP-loe and the related ~/chemokine, RANTES, induce transient alterations 
in intracellular Ca  2+  concentration in polymorphonuclear leukocytes  that can be reciprocally 
and specifically desensitized, suggesting a common receptor. Moreover, we have now cloned both 
the cDNA and the gene for this receptor, functionally expressed the receptor in Xenopus  oocytes, 
and mapped the gene to human chromosome 3p21. Transcripts for the receptor were found in 
mature and immature myeloid cells as well as B cells. The receptor is a member of the G 
protein-coupled receptor superfamily.  It has "~33%  amino acid identity with receptors for the 
oe chemokine, interleukin 8,  and may be the human homologue of the product of US28, an 
open reading frame of human cytomegalovirus. 
C 
hemokines are structurally and functionally related 8-10- 
kD peptides that are  the products of distinct genes 
clustered on human chromosomes  4 and 17. Chemokines  regu- 
late the traffcking and activation of lymphocytes and phago- 
cytes of the mammalian immune system. In addition, some 
are able to regulate the proliferative potential of hematopoi- 
etic progenitor ceils, endothelial ceils, and certain types of 
transformed cells  (reviewed  in references  1-3).  Thus,  the 
chemokines may play an important role in host defense against 
infection, in the pathogenesis of chronic inflammatory dis- 
orders,  and in wound healing. 
The chemokines can be divided into two groups, ot and 
8, by the arrangement of the first two of four conserved cys- 
teines. Members of the chemokine c~ group all possess a single 
amino acid of variable identity interposed between the first 
two cysteines. IL-8 is the best characterized  member of this 
group. Two human IL-8 receptors have been identified that 
are 77%  identical at the amino acid level (4,  5).  IL-SR B 
can also be activated by the related c~ chemokines, GROc~ 
and neutrophil activating peptide 2 (5,  6). 
The first two conserved cysteines of 3 chemokines are ad- 
jacent. The human chemokine 3 family includes macrophage 
inflammatory protein la (MIP-lo01, MIP-1B, regulated on 
activation,  normal T  expressed  and secreted  (RANTES), 
monocyte chemoattractant  protein  1  (MCP-1),  MCP-2, 
MCP-3, and 1-309 (3). The biological properties of MIP-la, 
RANTES, and MCP-1 have been the most characterized (Table 
1). Members of this group attract and activate PMN,  eo- 
sinophils, monocytes, and lymphocytes with variable selec- 
tivity (7-11). In addition, MIP-loe has been shown to regu- 
late  the proliferative  capacity  of myeioid progenitor cells 
(12-15). 
To more precisely delineate the role of chemokines in the 
inflammatory response and hematopoiesis, we wished to study 
the  structure  and  signal  transduction properties  of their 
receptors.  Here we report  the cloning of the cDNA  and 
the gene for the first chemokine ~  receptor,  the MIP-lcr 
RANTES receptor. 
I Abbreviations used in  this paper: MCP-1,  monocyte  chemoattractant 
protein 1;  MIP-lc~,  macrophage inflammatory protein la;  RANTES, 
regulated on activation, normal T  expressed and secreted. 
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The RNA and DNA isolation,  Northern and Southern blot anal- 
ysis, and DNA sequencing were done exactly as described (16). 
Intracelhlar Calcium Measurements in Blood Cells.  PMN  and 
PBMC were isolated from peripheral blood by Ficoll-Hypaque dis- 
continuous  density gradient  centrifugation.  PMN  were further 
purified by dextran sedimentation and hypotonic lysis. PMN were 
typically contaminated with '~5% eosinophils.  PBMC were -020% 
monocytes and  80%  lymphocytes.  Cells  (107/ml)  were washed 
with HBSS buffered with Hepes (10 mM, pH 7.4) and loaded with 
2.5 pM Indo-1 AM (Molecular Probes, Eugene, OR) for 30 min 
at 37~  in the dark.  The cells were subsequently washed twice 
with buffer and resuspended at 2  x  106 cells/ml. 3 ml of the cell 
suspension was placed in a continuously stirred, quartz cuvette main- 
tained at 37~  (DeltaScan; Photon Technology International Inc., 
S. Brunswick, NJ). Fluorescence  was monitored at K.~ =  358 nm 
and  ~m  m  402 nm (bound) and 486 nm (free),  and the data are 
presented as the bound/free ratio. Data were collected every 200 
ms.  The  Rm~  and  Rmin were  empirically  obtained  by  adding 
ionomycin (1 pM) and EGTA (10 mM), respectively.  The dissocia- 
tion constant of Indo-1 (Ka  =  250 riM) was used to transform 
the data to [CaZ+]i in the relationship [Ca  2+]  =  Ka. [(K  -  Rmin) 
+  (Rm,~ -  R)"  (Sfe/Sb2)(17). 
eDNA and Genomic Library Screening.  A 2-kb Hit60 neutro- 
phil cDNA library in h ZAP (Stratagene, La Jolla, CA) was screened 
with a 32p-labded oligonucleotide probe corresponding to nucleo- 
tides 238-276  of the cDNA sequence of clone F3K,  which en- 
codes the rabbit IL8K (18), exactly as described (5). DNA sequences 
were determined on both strands of the two longest hybridizing 
clones, designated p4 and p7. A human genomic library in ~ FIX 
(Stratagene)  was  screened  exactly as described  (19) with  a  3zp. 
labeled  probe of p4  cDNA  synthesized  from random  primers. 
Restriction sites of positive clones were mapped and a 6.5-kb XbaI 
fragment was sequenced. 
Calcium E.fftu.x Assay.  cRNA was prepared exactly as previously 
described (5). The materials and methods used for the calcium dtlux 
assay were as described (5) with minor modifications. Defollicu- 
lated oocytes from Xenopus laevis were microinjected with RNA 
samples 1-2 d after harvesting and were then incubated at 20-23~ 
for 3-5 d. Oocytes were then incubated with 45Ca2+ (100/.LCi/ml; 
Amersham Corp., Arlington Heights, IL) for 4 h. After 10 washes 
with medium, individual oocytes were stimulated with ligands. 
Data are presented as the mean  _+  SEM of the percent of loaded 
4SCa  2+  that was released  in 20 rain by individual oocytes in re- 
sponse to the stimulus. Recombinant human ligands were obtained 
as follows:  MIP-lc~  (R & D  Systems,  Minneapolis,  MN);  I1_,8, 
Table  1.  The Human Chemokine ff Family of Proinflammatory Peptides 
Percent identity to 
mature MIP-lc~ 
Chemokine*  (sequence  accession  no.)  Source*  Targets/actions 
MIP-la  100  (D90144)  B &  T  lymphocytes 
Mast cells 
Fibroblasts 
Macrophages 
Monocytes 
MIP-1B  67  (B30574)  B &  T  lymphocytes 
Macrophages 
Monocytes 
RANTES  46  (M21121)  T  lymphocytes 
Platelets 
1-309  38  (M57506)  T  lymphocytes 
MCP-1  39  (M24545)  Monocytes 
Endothelial  cells 
Fibroblasts 
Keratinocytes 
MCP-2  40 (P80075)  MG-63 osteosarcoma 
cells 
MCP-3  34 (P80098)  MG-63 osteosarcoma 
cells 
Neutrophil  and  monocyte chemotaxis;  ~11 
neutrophilSll  and macrophageS activation;  stem 
cell  suppression; potentiation  of GM-CFU 
stimulation by GMCSF;S  PGE-independent 
endogenous pyrogenSII 
Inhibits MIP-lcr action on stem cells; s 
potentiates GM-CFU  stimulation  by GMCSF; s 
inhibits  macrophage activation by MIP-lc~S 
Monocyte,  granulocyte,  and memory 
T  lymphocyte (CD4+/CD45Ro +) 
chemotaxis 
Mouocyte chemotaxis 
Monocyte chemotaxis and activation; 
tumor suppression  s 
Monocyte chemotaxis 
Monocyte chemotaxis 
* Additional information regarding alternative names and sequence variants of human and murine B chemokines can be found in references 1-3. 
* The sources listed are based on protein purification and/or chemokine RNA distribution in normal human cell types with the exception of MCP-2 
and MCP-3, for which information is currently available only for the transformed cell type from which they were purified. 
S Activities so far reported only for the murine homologue. 
It Activities so far reported only for native murine MIP-1, which is purified as a heterodimer of MIP-I~ and MIP-1/~. Human and routine forms 
of mature MIP-lc~ and MIP-lfl peptides are 74 and 77% identical in amino acid sequence, respectively. 
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(Bachem, Philadelphia, PA); and GRO~ (a gift from M. P. Beck- 
mann, S. Lyman, and D. Cerretti, Immunex Corp., Seattle, WA). 
The MIP-I~ and MIP-1B used in the initial ligand screen (see Fig. 2 
A) was a gift of U. Siebenlist (National Institute of Allergy and 
Infectious Diseases) and was used as a diluted supernatant of Sf9 
insect cells expressing  immunoreactive  recombinant  human MIP-lc~ 
(from clone pAT464) or MIP-1B (from clone pAT744) (20). All 
proteins were diluted from aqueous stock solutions or culture su- 
pernatants into ND96 oocyte media (96 mM NaC1, 1 mM KC1, 
1 mM MgC12, 1.8 mM CaC12, pH 7.45) containing 0.1% BSA. 
Radioligand Binding Assay.  Carrier-flee recombinant human 
MIP-lc~ (10  /~g) was  labeled using  5 mCi NanSI (Amersham 
Corp.) in 100/~10.2 M sodium phosphate, pH 7.2, and 50 #1 recon- 
stituted Enzymobeads (Bio-Rad Laboratories, Richmond, CA) as 
previously described (5). The specific activity was 300 Ci/mmol. 
The labeled protein migrated as a single band on a 14% polyacryl- 
amide gel and was functionally active (not shown). Single oocytes 
were incubated with nSI-MIP-lcr for 30 min on ice in 10 #1 of 
binding buffer (HBSS with 25 mM Hepes, 1% BSA, pH 7.4). Un- 
bound ligand was removed  by centrifugation of the oocyte through 
300 #1 of  PS0 silicone  fluid (General  Electric, Waterford, NY). The 
tubes were quickly frozen and 3, emissions from the amputated 
tips were counted. 
Chromosomal  Localization.  For primary assignment, a panel of 
11 Chinese hamster x human hybrid cell lines were used (21). For 
regional localization, four rodent  x  human hybrid cell lines were 
used that contained either the short arm or the long arm of chro- 
mosome 3 in the absence of an intact chromosome 3. DNA from 
somatic cell hybrids and controls were analyzed  by PCR using the 
open reading frame primers. The PCR conditions were 95~ 
5 min; then 30 cycles  of 94~  I min; 55~  1 min; 72~  I min. 
Fine mapping was performed as described (22) by fluorescence  in 
situ hybridization  to peripheral  lymphocyte  metaphase  chromosomes 
of a 46, XY normal male with a biotin-labeled genomic 6.5-kb 
XbaI fragment containing the MIP-lc~/RANTES receptor gene. 
Results and Discussion 
Activation o  S PMN by MIP-lol and RANTES.  The o~ 
chemokines have previously been shown to mobilize calcium 
in PMN (1-3).  The ~  chemokines MIP-lc~ and RANTES 
were also able to elicit rapid, transient elevations of [Ca2+]i 
in human PMN  (Fig.  1 A)  with ECs0 of 5  and 50  aM, 
respectively  (Fig.  1, B and C). In contrast, MCP-1 elicited 
an elevation in [Ca2+]i in PBMC (Fig.  1 A, traces e and J) 
but not in PMN (Fig. 1 A, trace d). These data suggest that 
PMN possess receptors  for MIP-lc~ and RANTES but not 
MCP-I.  Crossdesensitization experiments performed with 
MIP-lc~, RANTES, and MCP-1 with PMN and PBMC sug- 
gested that putative PMN receptors for MIP-lol and RANTES 
may be identical (Fig.  1 A). 
Cloning of cDNA for  the MIP-lcr/RANTES  Receptor. 
During the cloning ofcDNA for human IL-8R B (5), a related 
but  distinct class  of four HL-60  neutrophil cDNAs  was 
identified. The longest cDNA of this group was designated 
p4. The p4 cDNA is 2,165 bp in length; the longest open 
reading frame is 1,065 bp, encoding a protein of 355 amino 
acids￿9 The proposed codon for initiation of translation and 
its flanking sequence is GGGATGG, which conforms favor- 
ably to the consensus rules (23). The 5'- and 3'-untranslated 
regions are 102 and 998 bp long, respectively. A poly(A) tail 
is present. 
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Figure 1.  MllXlc~  and RANTES 
elicit transient elevation  of [Ca  2  +  ]i 
in  human leukocytes. (A) PMN 
(traces a-d) or PBMC (traces e-J) 
were loaded with Indo-1 and then 
stimulated at the indicated times 
with buffer, 10 aM MIP-lo~, 100 
aM RANTES, or 50 aM MCP-1. 
Alterations  in the bound/free  ratio 
reflect changes in the [Ca2+]i as de- 
scribed in Materials and Methods. 
(/3 and C) Ligand  concentration  de- 
pendence  of calcium  mobilization  in 
PMN by MIP-I~ and RANTES. 
Data are representative  of four sep- 
arate experiments with MIP-I~, 
two with RANTES, and one with 
MCP-1. 
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Figure  2.  Functional  expression  of  the  MIP-lo~/ 
RANTE$ z~ceptor in Xenopus oocytes. (A) The p4 cDNA 
encodes a receptor  selective for a fl chemokine.  5 d after 
injection with 10 ng of either p4 cRNA (filled bars) or 
IL-SR B cRNA (open bars), oocytes were stimulated with 
human rlb-8, GROom, or NAP-2 at 500 nM, or a 1:5 dilu- 
tion of an SD supernatant containing recombinant human 
MIP-I~ or MIP-lfl. Neither MIP-lcx nor MIP-lfl acti- 
vated IL-SR B. (B) The p4 cDNA encodes a promiscuous 
receptor for MIP-lcx and RANTES. Oocytes were injected 
with 10 ng p4 cRNA and stimulated  3 d later with the 
indicated recombinant human B chemokines. Oocytes that 
had been injected with 50 nl of water did not respond 
to MIP-lcx, RANTES, or MCP-1 over the same concen- 
tration range  (not shown).  The SEM was <10% of the 
mean value. Data are from a single experiment  represen- 
tative of four separate experiments.  In A and B, the data 
are derived from five to eight replicate determinations  per 
point. Basal amounts  of calcium efl]ux and calcium up- 
take were similar for all experimental conditions.  (C and 
D) Binding of 1~I-MIP-Ir  to oocytes injected with p4 
cRNA. (C) Total (filled circles) and nonspecific (open circles) 
binding was determined  by incubating oocytes injected 
with p4 cKNA with the indicated concentration  of radio- 
ligand in the absence or presence of a 100-fold molar excess 
of unlabeled MIP-lc~, respectively. Nonspecific binding 
was subtracted  from total binding to determine  specific 
binding (open  squares).  Specific binding of ~2SI-MIP-la to oocytes expressing  IL-SR B was undetectable.  (D)  Oocytes  injected with p4 cR.NA  were 
incubated  with 100,000 cpm 12SI-MIP-1ot in the presence or absence of the indicated  concentration  of unlabeled  MIP-lc~.  100%  represents  a mean 
of 6,401 cpm.  Data in C  and D  are derived from triplicate  determinations  per point. 
To determine whether IL-8 or a related molecule could 
activate the p4 product, Xenopus oocytes were injected with 
p4 cRNA and calcium efflux was measured in response to 
a test panel of ligands. Oocytes injected with p4 cRNA ac- 
quired responsiveness  to MIP-la and RANTES but not to 
MIP-1B,  MCP-1,  or any of three ot chemokines that were 
tested (Fig.  2, A  and B).  The ECs0 for P.ANTES was •50 
nM, similar to that observed for activation of a calcium flux 
response in PMN by this chemokine (Figs.  1 C  and 2 B). 
The oocyte response to MIP-lc~ is specific for the entire con- 
centration range tested. However, it has two phases, one that 
appears to saturate at 100 nM MIP-lo~ and a second that did 
not reach a plateau at 5,000 nM MIP-la (not shown). The 
first plateau coincides with that demonstrated for PMN over 
this concentration range (Figs.  1 B  and 2 B). 
The  threshold  for detection of specific binding  of 1251- 
MIP-lcx  to  oocytes injected with  the p4  cRNA  was  the 
same as that required for stimulation of calcium efflux. 12sI- 
MIP-lo~ did not bind specifically to oocytes expressing human 
IL-8R B. Specific binding was also detected in COS-7 cells 
transfected with p4 in the vector pcDNAI, but not in un- 
transfected COS-7 cells (not shown). However, at high con- 
centrations the ligand formed aggregates causing a high back- 
ground of nonspecific binding that precluded determination 
of the binding constant. 
Tissue Distribution of the MIP-lcr/RANTES  Receptor.  A 
p4 probe hybridized with a single 3-kb band on blots of RNA 
from the human myeloid precursor cell lines HL-60, U937, 
and THP-1, from HL-60 cells differentiated with dibutyryl 
cAMP (HL-60 neutrophils), and from human B lymphocytes. 
Transcripts were not detectable in total RNA from T  lyre- 
phocytes activated with PHA,  the transformed T  cell line 
Jurkat, EBV-transformed B cells (Fig. 3), and from 10 non- 
hematopoietic tissues (not shown). This broad expression pat- 
tern in mature and immature cells of the immune system is 
unique among all known chemoattractant receptors and, to 
Figure  3.  Distribution of mRNA encoding  the MIP-I~/RANTES 
receptor. Each lane contains  10/Lg of total cellular RNA from the indi- 
cated source with the exception of the lane designated HL60  poly(A) +  , 
which contains 10/zg of  polyadenylated RNA from undifferentiated Hb60 
cells. The blot was hybridized with a p4 probe and was washed at 68~ 
in 0.1x  SSPE for 1 h. The blot was exposed to XAR-2 film in a Quanta 
III cassette at 80~  for 6 d. The position  of ribosomal RNA is indicated 
with arrows. 
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virtue of the abundant expression in B lymphocytes. We have 
not tested monocyte  RNA by blot hybridization but instead 
have cloned MIP-lcffRANTES receptor cDNAs from an 
endotoxin-stimulated human monocyte  library (Ahuja, J. K., 
and P. M. Murphy, unpublished data). 
The distribution of MIP-lot/RANTES receptor transcripts 
differs from the pattern expected based on the functionally 
defined targets  of RANTES action in two regards.  First, 
RANTES is known to attract "memory" T lymphocytes (7), 
but total RNA from peripheral blood T cells activated with 
PHA did not contain detectable transcripts. Thus: (a) either 
the receptor gene is expressed at very low constitutive levels 
in T cells; (b) the receptor gene is turned offby PHA treat- 
ment of the cells; or (c) the RANTES receptor of T cells 
is distinct from the receptor we have described. Second, MIP- 
lc~/RANTES receptor transcripts are expressed at high levels 
in B cells, a cell type that reportedly is  not a target for 
RANTES action (7). Perhaps the cellular environment in 
which the receptor is expressed determines the precise effector 
function that can be activated. 
Structural Comparison with the IL-SR and with CMV-US28. 
The MIP-lot/RANTES receptor contains seven  hydrophobic 
segments predicted to span the plasma membrane, a signa- 
ture of receptors that are known to be coupled to heterotri- 
meric G proteins (24). As expected, its closest known struc- 
tural homologues are human IL-SR A  (31%  amino acid 
identity) and B  (33%  identity); the lengths of all  three 
receptors are "~355 amino acids (Fig. 4).  Interestingly,  the 
open reading frame US28 of human cytomegalovirus  (25) 
encodes a protein that is similar in sequence to the MIP-lc~/ 
RANTES receptor (33%  amino acid identity). 
The NHz-terminal segment is poorly conserved for even 
closely related G protein-coupled receptors, including IL-8R 
A  and B  (4-6).  Not  surprisingly  the MIP-lot/RANTES 
receptor has limited sequence identity with the IL-SRs in 
this region. Nevertheless,  the three known chemokine re- 
ceptors and US28 all have addic NH2-terminal domain; the 
net  charge for  IL-SR  A  and  13,  the MIP-lcffRANTES 
receptor,  and  US28  is  -9,  -11,  -6,  and  -6,  respec- 
tively. This is very uncommon in other G protein-coupled 
receptors (P. M. Murphy, unpublished  analysis). It is note- 
worthy that MIP-lc~ and RANTES, like other chemokines, 
are basic polypeptides and could bind via charge interactions 
with the extraceUular  NH2-terminal domain of the receptor. 
In contrast to the IL-SKs the NH~-terminal sequences of 
the MIP-lodRANTES receptor and US28 are surprisingly 
similar (56% identity), further highlighting the special evolu- 
tionary relationship of these two products. Cytomegalovirus 
is known to infect myeloid and lymphoid cells in vivo (26), 
cell types that express the MIP-lodRANTES receptor. Others 
have speculated that US28 was acquired by viral hijack of 
a human gene (25). Thus, the hijacked human gene may be 
for a/~ chemokine receptor. We speculate that expression of 
US28 may alter the responsiveness  of infected lymphoid and/or 
myeloid cells to MIP-loe, R.ANTES, or another ~ chemokine. 
In this way the intraceUular environment may be rendered 
more favorable for viral replication and/or establishment of 
the latent state. Viral hijack of immunoregulatory  ligand and 
receptor genes has been reported for pox and herpes viruses. 
These and other viruses may use the viral homologues to 
elude the immune system by molecular mimicry (reviewed 
in reference 27). We have cloned US28 by PCR from fibro- 
blasts acutely infected with human cytomegalovirus. No cross- 
hybridizing human genes were detected by blot hybridiza- 
tion of human genomic DNA with a full-length US28 DNA 
probe under low stringency conditions  (final wash at 45~ 
in 5 x  SSPE; data not shown). 
Analysis of the MIP-loe/RANTES Receptor Gene.  Anal- 
ysis of human genomic DNA by blot hybridization with a 
p4 probe under high and low (45~  5 x  SSPE) stringency 
conditions indicated that the MIP-lot/RANTES receptor must 
be encoded by a small, single-copy  gene that lacks dose homo- 
logues in human (Fig. 5 A). Thus, unshared receptors selec- 
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Figure 4.  Primary  structure of the human MIP-lot/R.ANTES  receptor (MIP-lotR) and alignment with that of human IDSIL B (5) and CMV-US28 
(25). Vertical  bars indicate  identical  residues  for each adjacent  sequence  position; colons indicate  residues  that are identical  for US28 and IL-8R B but 
differ from MIP-lc~R. The locations of predicted membrane-spanning  segments  I-VII are noted. Open boxes designate  predicted  sites for N-linked 
glycosylation.  Arabic  numbers above  the sequence  blocks refer  to the MIP-I~.R sequence  and are left  justified. Dashes  indicate  gaps that were  inserted 
to optimize the alignment. The DNA sequence  of p4 has been submitted to GenBank under accession number L10918. 
1425  Gao et al. Figure 5.  Analysis of  the  human 
MIP-lce receptor gene. (A) A blot of 
human genomic DNA digested with 
the indicated restriction endonucleases 
was  hybridized  with  the  p4  cDNA 
(washed at 68~  in 0.1x  SSPE), The 
blot was exposed to XAK-2 film in a 
Quanta III cassette at  -80~  for 6 d. 
DNA markers are in kilobases at the 
left. No crosshybridizing  genes were de- 
tected under the low stringency condi- 
tions (washed at 45~  in 5x  SSPE). 
The open reading frame of the MIP-lo~/ 
KANTES receptor gene has a restric- 
tion site for EcoRI and for Pstl.  (B) 
Chromosomal localization.  Ideogram of 
G-banding  pattern of human chromo- 
some 3 with vertical bars illustrating 
the regions present in somatic cell hy- 
brid lines. PCK amplification  results are 
summarized below:  +, hybrid positive; 
and  -,  hybrid  negative  for  human 
MIP-Io~/RANTES receptor sequence. 
Bracket labeled SCH shows localization 
of the gene based on hybrid cell map- 
ping data. Bracket labeled FISH indi- 
cates localization of fluorescent in situ 
hybridization  signals at 3p21. 
tive for MIP-lc~ and/or RANTES, if they exist, must be struc- 
turally quite divergent from the receptor described here. The 
6.5-kb XbaI fragment seen in Fig. 5 A was cloned and se- 
quenced.  An intron-exon boundary is found at nucleotide 
-12 relative  to the ATG initiation codon, but the open reading 
frame and 3' flanking sequences  lack introns, a common finding 
for G protein-coupled receptor genes. By using primers specific 
for the human MIP-lodRANTES receptor cDNA for PCR 
amplification of DNA from rodent  x  human somatic cell 
hybrid mapping panels, we have localized the gene to the 
short arm of chromosome 3.  Independent confirmation of 
this assignment and further sublocalization of this gene to 
band 3p21 was accompanied by fluorescence in situ hybrid- 
ization  (FISH) of the 6.5-kb genomic XbaI fragment con- 
taining the gene (Fig. 5 B). The IL-SR genes are clustered 
on human chromosome 2q34-q35  (19). 
MIP-lot has been shown to regulate the growth of stem 
cells and other more mature myeloid precursors (12-15). The 
effects of related chemokines, including KANTES, on he- 
matopoiesis have  not yet been reported.  It will be important 
to study whether all or only some of the known effects  of 
MIP-lol and KANTES are mediated by the receptor described 
here. If so, the structure of this receptor suggests that the 
signal transduction mechanism(s) for these disparate effects 
will involve G protein(s). 
The MIP-lcffRANTES receptor is the first receptor for 
a  hematopoietic  growth regulator in  the  superfamily  of 
receptors with seven transmembrane domains. Identification 
of the human MIP-lodRANTES receptor will now facili- 
tate precise delineation of the signal transduction pathways 
by which MIP-lot and RANTES activate responsive cells of 
the hematopoietic  system and may lead to new insights re- 
garding the pathophysiology  of fever and wound healing as 
well as myelopoiesis and chemotaxis. Moreover, the relation- 
ship of the MIP-lo~/RANTES receptor and US28 will permit 
the investigation of new hypotheses regarding the pathogen- 
esis of human cytomegalovirus infection. 
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